{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-006009","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.454853+00:00","generated_at":"2026-05-23T07:08:24.857177+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"confidence":"high","headline":"Ensysce raises $2.2M via warrant exercise inducement; issues new warrants for 1.26M shares","bullets":["Holders exercised 630,376 warrants at $3.24/share for cash; gross proceeds ~$2.2M before fees.","Company issued new unregistered warrants to purchase 1,260,752 shares at $1.90, split 18-month and 5-year terms.","Net proceeds ~$1.9M to fund TAAP and MPAR programs and working capital.","H.C. Wainwright acted as placement agent; received 7% cash fee and 44,126 agent warrants at $4.05.","New warrants include 4.99% beneficial ownership limitation (9.99% at holder election)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-006009","json":"https://secwatch.observer/filing/0001641172-25-006009.json","markdown":"https://secwatch.observer/filing/0001641172-25-006009.md","text":"https://secwatch.observer/filing/0001641172-25-006009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/0001641172-25-006009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T07:08:24.857177+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}